Dr. Anthony Eugene Oro, MD

Dr. Oro practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Oro's NPI, 1902963853, was assigned on January 2, 2007. Dr. Oro graduated from UC San Diego School of Medicine in 1993. Dr. Oro's California license number on file is G79854.

Dr. Oro's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Oro's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Oro to 1 more hospital and 1 medical group, each named with a free account. Dr. Oro's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oro practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Oro's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Oro is board certified in dermatology by the American Board of Dermatology. Dr. Oro has a license on file in California.

Dmand AI lists benign or precancerous skin growths, contact dermatitis, rash, scalp rash, skin cyst and skin discoloration among the conditions Dr. Oro treats.

CMS data shows 156 Medicare services from Dr. Oro across 2 procedure codes in 2024, all of them office visits, for 114 Medicare patients. Medicare paid $11,759 for them. Every service was in an office.

CMS counts 114 Medicare patients who saw Dr. Oro in 2024. The largest group is 65 to 74, with 67 patients. 73% of them have high cholesterol, and 47% have high blood pressure. Their average risk score is 0.83, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Oro's median patient age at 58, with 70% women.

In 2024, Dr. Oro wrote 740 Medicare Part D claims for 102 patients. 98% of them were for generic drugs. CMS names the drug for 692 of them, across 9 drugs with 11 or more claims each, at $55,636 in total drug cost. In 2023, CMS named 542 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Oro for performance year 2024, reported as part of a group. Dr. Oro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Oro as offering telehealth. CMS counts 23 procedures of removal of skin lesions by Dr. Oro, more than 66% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 125 papers to Dr. Oro, published from 2006 to 2025. 2018 was the busiest year, with 8. The most frequent topics are Carcinoma, Basal Cell, Skin Neoplasms and Signal Transduction. Dr. Oro has published most often in J Invest Dermatol. Dr. Oro's most frequent co-authors are Anne Lynn Su Chang, MD, Kavita Yang Sarin, MD and Sumaira Zareen Aasi, MD.

Dmand AI links Dr. Oro to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Carcinoma, Basal Cell, Neoplasms, Basal Cell and Epidermolysis Bullosa Dystrophica.

CMS Open Payments shows 5 general payments to Dr. Oro from 3 drug and device companies from 2020 to 2024. Consulting fees make up the largest share, 97% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $3,100.

Dmand AI lists 3 awards for Dr. Oro, most recently CMS Stage 1 EHR in 2013.

Dr. Oro graduated from UC San Diego School of Medicine in 1993.

Dr. Oro is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.